Medipharm Labs Corp
TSX:LABS
Medipharm Labs Corp
Net Change in Cash
Medipharm Labs Corp
Net Change in Cash Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medipharm Labs Corp
TSX:LABS
|
Net Change in Cash
-CA$8.5m
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Net Change in Cash
$1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
2%
|
CAGR 10-Years
10%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Net Change in Cash
-CA$56.5m
|
CAGR 3-Years
47%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Net Change in Cash
CA$25.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Net Change in Cash
-$53.8m
|
CAGR 3-Years
20%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Net Change in Cash
CA$17m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-16%
|
|
Medipharm Labs Corp
Glance View
MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company is headquartered in Barrie, Ontario and currently employs 190 full-time employees. The company went IPO on 2018-02-09. The firm produces purified, pharmaceutical-like cannabis extracts and related derivative products. The firm formulates, processes, packages and distributes cannabis extracts and cannabinoid-based products at its Canadian and Australian facilities for domestic and international markets. The Company, through its subsidiaries is engaged in the sale and distribution of cannabis oil, cannabis extracts, cannabis edibles, cannabis topicals, and derivatives to authorized classes of purchasers, as well as controlled human administration trials for sensory testing of cannabis extracts and derivative products. The company is also engaged in the manufacturing of extracts and tinctures of cannabis and cannabis resin for the purpose of a clinical trial or prescribed as medical cannabis products. The firm's wholly owned subsidiaries include MediPharm Labs Inc. and MediPharm Labs Australia Pty. Ltd.
See Also
What is Medipharm Labs Corp's Net Change in Cash?
Net Change in Cash
-8.5m
CAD
Based on the financial report for Mar 31, 2025, Medipharm Labs Corp's Net Change in Cash amounts to -8.5m CAD.
What is Medipharm Labs Corp's Net Change in Cash growth rate?
Net Change in Cash CAGR 3Y
15%
Over the last year, the Net Change in Cash growth was -164%. The average annual Net Change in Cash growth rates for Medipharm Labs Corp have been 15% over the past three years .
You don't have any saved screeners yet